PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsparkinson disease
MeSH D010300 - parkinson disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020734:Parkinsonian disorders
1 Company
1 Drug
$
Success rate
D000080874:Synucleinopathies
0 Companies
0 Drugs
Success rate
D010300: 
Parkinson disease
107 Companies
30 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmantadine Amantadine  1991-08-23   
Rasagiline Azilect 2026-12-05 2006-05-16   
Cabergoline Cabergoline  2007-03-07   
Entacapone Entacapone Teva  2011-02-18   
Pergolide Pergolide  2003-09-04   
Pramipexole Pramipexole Teva  2008-12-18   
Rasagiline Rasagiline ratiopharm  2015-01-12   
Rivastigmine Rivastigmine Teva  2009-04-17   
Novast LaboratoriesPramipexole Pramipexole  2022-02-03   
Tolcapone Tolcapone  2018-08-07   
PadagisBromocriptine Bromocriptine  2008-10-01   
Glenmark PharmaceuticalsPramipexole Pramipexole  2010-10-08   
Ropinirole Ropinirole  2010-02-25   
IngenusCabergoline Cabergoline  2018-08-01   
MylanBromocriptine Bromocriptine  2005-04-04   
Cabergoline Cabergoline  2013-12-02   
Levodopa, Carbidopa hydrate Carbidopa Levodopa  1999-09-30   
Entacapone, Levodopa, Carbidopa hydrate Carbidopa, Levodopa Entacapone  2020-08-13   
Entacapone Entacapone  2013-05-13   
Rasagiline Rasagiline Mylan  2016-04-04   
Ropinirole Ropinirole  2008-05-05   
NATCO PharmaPramipexole Pramipexole  2010-10-08   
Aurobindo PharmaRopinirole Ropinirole  2012-10-15   
Levodopa, Carbidopa hydrate Carbidopa Levodopa  2022-11-28   
Entacapone Entacapone  2015-06-19   
Pramipexole Pramipexole  2012-10-26   
Rasagiline Rasagiline  2017-05-15   
Bromocriptine Bromocriptine  2004-09-24   
Safinamide Safinamide  2023-06-14   
Amantadine Amantadine  1994-10-28   
GSKRopinirole Requip  1997-09-19   
RocheLevodopa Larodopa  1982-01-01   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
64%
62/97
Phase 2
46%
72/155
Phase 3
59%
64/108
Approved: 33Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Rasagiline,
Pramipexole,
Dexpramipexole,
Phenylalanine,
Bevifimod,
Nepidermin,
TALAMPANEL,
Ipx066
Mylan
Bromocriptine,
Bromocriptine mesylate
GSK
Ropinirole,
Benzocaine,
Dexpramipexole,
Leucine,
Phenylalanine,
Aspartame,
Nepidermin,
Ipx066
Roche
Levodopa,
Leucine,
Aspartame,
Prasinezumab
Sandoz
Pramipexole,
Bromocriptine,
Bromocriptine mesylate,
Dexpramipexole
Boehringer Ingelheim
Pramipexole,
Dexpramipexole,
Phenylalanine,
Bevifimod,
TESOFENSINE,
Ipx066
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use